Squamous Cell Carcinoma of the Paranasal Sinus
Also known as: Paranasal Sinus Squamous Cell Carcinoma / Squamous Cell Carcinoma (SCC) of the Paranasal Sinuses / Malignant neoplasm of accessory sinus, unspecified / Malignant neoplasm of accessory sinuses / Primary malignant neoplasm of accessory sinus (disorder) / Malignant tumor of nasal sinuses (disorder) / Nasal sinus cancer / Malignant neoplasm of accessory sinus NOS (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 1 | Active Not Recruiting | 1 |
| DB05643 | IRX-2 | 1 | Active Not Recruiting | 1 |
| DB00002 | Cetuximab | 1 / 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Active Not Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
| DB01101 | Capecitabine | 2 | Terminated | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB02546 | Vorinostat | 2 | Terminated | 1 |